Nuwellis, Inc. Common Stock
NUWE Real Time Price USDRecent trades of NUWE by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NUWE's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
NUWE Revenue by Segment or Geography
New patents grants
-
Patent Title: Venous blood flow stimulator for extracorporeal therapy Jun. 18, 2024
-
Patent Title: Extracorporeal blood filtering machine and methods Jun. 04, 2024
-
Patent Title: Extracorporeal blood filtering machine and methods May. 21, 2024
-
Patent Title: Extracorporeal blood filtering machine and methods Jan. 09, 2024
-
Patent Title: Extracorporeal blood filtering machine and methods Nov. 14, 2023
-
Patent Title: Venous blood flow stimulator for extracorporeal therapy Oct. 24, 2023
-
Patent Title: Blood filtration systems Apr. 25, 2023
-
Patent Title: Neonatal and pediatric blood filtration system Aug. 23, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to NUWE
Recent picks made for NUWE stock on CNBC
ETFs with the largest estimated holdings in NUWE
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NUWE stock a Buy, Sell, or Hold?
- What is the price target for $NUWE stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NUWE stock?
- Who owns the most shares of $NUWE stock?
- What funds own $NUWE stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NUWE Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.